19
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Modern Contraceptive Choice Among Patients Seen at the “Cameroon National Planning Association for Family Welfare” Clinic Yaoundé

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND

          To understand the low modern contraceptive prevalence in Cameroon, we reviewed the methods chosen and determined their side effects among patients in an urban setting.

          METHODS

          We conducted a cross-sectional study at the “Cameroon National Planning Association for Family Welfare (CAMNAFAW) Clinic” in Yaoundé. Data were processed by SPSS software version 20.0 for Windows, and all tests were considered statistically significant at P < .05.

          RESULTS

          Of the 1180 women sampled, the most chosen methods were as follows: depot medroxy progesterone acetate: 72.1% (787 of 1091), followed by oral combined contraceptives: 21.3% (232 of 1091), subcutaneous implants: 3.2% (35 of 1091), and intrauterine contraceptive devices: 1.9% (21 of 1091). A hundred and forty two (14.5%) of the 977 women received at least once (revisits) at the Center, reported at least one side effect. Irregular vaginal bleeding was the most frequent side effect: 44.6% (84 of 188 total documented side effects). Side effects were most common among users of subcutaneous implants: 28% (7 of the 25 implant users).

          CONCLUSIONS

          Prescription of contraceptives should reflect not only the desire of couples but also the side effects associated with each method. This would optimize observance and adherence, consequently decreasing the failure rate.

          Related collections

          Most cited references17

          • Record: found
          • Abstract: found
          • Article: not found

          Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.

          (2012)
          Long-acting reversible contraception (LARC)—intrauterine devices and the contraceptive implant—are safe and appropriate contraceptive methods for most women and adolescents. The LARC methods are top-tier contraceptives based on effectiveness, with pregnancy rates of less than 1% per year for perfect use and typical use. These contraceptives have the highest rates of satisfaction and continuation of all reversible contraceptives. Adolescents are at high risk of unintended pregnancy and may benefit from increased access to LARC methods.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Determinants of contraceptive usage: lessons from women in Osun state, Nigeria

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen.

              To estimate real-life effectiveness of oral contraceptive pills by progestogen, length of pill-free interval, and body mass index while focusing on the effect of progestogens with a long half-life and on 24-day oral contraceptive pills regimens. Outcome data from 52,218 U.S. participants in the International Active Surveillance of Women Taking Oral Contraceptives—a large, prospective, controlled, noninterventional, long-term cohort study with active surveillance of the study participants—were used to analyze contraceptive failure in association with oral contraceptive pills use. Low loss to follow-up is ensured by a comprehensive follow-up procedure. Contraceptive failure rates are described by Pearl Index and life-table analysis. Inferential statistics for contraceptive failure are based on Cox regression models. Analyses are based on 1,634 unintended pregnancies during 73,269 woman-years of oral contraceptive pills exposure. Life-table estimates of contraceptive failure for a 24-day regimen of drospirenone and ethinyl estradiol and 21-day regimens of other progestogens were 2.1% and 3.5% after the first study year, and 4.7% and 6.7% after the third year. The adjusted hazard ratio was 0.7 (95% confidence interval 0.6–0.8). Direct comparisons of the 24-day and 21-day regimens of drospirenone and norethisterone, respectively, showed also lower contraceptive failure rates for 24-day regimens. Contraceptive failure rates adjusted for age, parity and educational level showed a slight increase with higher body mass index. The 24-day oral contraceptive regimens containing a progestogen with a long half-life show higher contraceptive effectiveness under routine medical conditions compared with conventional 21-day regimens. Obesity seems to be associated with a slight reduction of contraceptive effectiveness. ClinicalTrials.gov, www.clinicaltrials.gov, NCT00335257. II
                Bookmark

                Author and article information

                Journal
                Clin Med Insights Reprod Health
                Clin Med Insights Reprod Health
                Clinical Medicine Insights: Reproductive Health
                Clinical Medicine Insights. Reproductive Health
                SAGE Publications (Sage UK: London, England )
                1179-5581
                2017
                22 June 2017
                : 11
                : 1179558117713016
                Affiliations
                [1 ]Department of Obstetrics and Gynecology, Faculty of Medicine and BioMedical Sciences, University of Yaoundé I, Yaoundé, Cameroon.
                [2 ]Department of Obstetrics and Gynecology, Higher Institute of Medical Technology of Nkolondom, Yaoundé, Cameroon
                [3 ]Obstetrics and Gynecology Unit, Yaoundé Central Hospital, Yaoundé, Cameroon
                [4 ]Research, Education and Health Development Group “GARES-Falaise,” Dschang, Cameroon
                [5 ]Department of Disease Control, Ministry of Public Health, Yaoundé, Cameroon
                [6 ]Obstetrics and Gynecology Unit, University Teaching Hospital of Yaoundé, Yaoundé, Cameroon.
                Author notes
                CORRESPONDING AUTHOR: Fouelifack Ymele Florent, Department of Obstetrics and Gynecology, Faculty of Medicine and BioMedical Sciences, University of Yaoundé I, Yaoundé, Cameroon. Email: yfouelifack@ 123456yahoo.fr
                Article
                10.1177_1179558117713016
                10.1177/1179558117713016
                5484599
                36697996-4034-4541-9734-a5854cfde498
                © The Author(s) 2017

                This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ( http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page( https://us.sagepub.com/en-us/nam/open-access-at-sage).

                History
                : 04 July 2016
                : 10 May 2017
                Categories
                Original Research

                modern,contraceptive choice—side effects,women,family planning,cameroon

                Comments

                Comment on this article